Results 221 to 230 of about 125,233 (359)
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome [PDF]
Niraj R. Chavan+4 more
openalex +1 more source
Using narrative and informational messages to improve correctional professionals' attitudes toward medications for opioid use disorder. [PDF]
Harrell-Webber A+5 more
europepmc +1 more source
ABSTRACT Objective The objective of this study was to investigate the efficacy of transcutaneous auricular vagal nerve stimulation (taVNS) in adult patients with chronic constipation. Design Consecutive patients who met the Rome IV criteria for chronic constipation were enrolled and randomly assigned to either the taVNS group or the sham‐taVNS group ...
Tangyi Liu+19 more
wiley +1 more source
Prediction of individualised 6-month mortality risk in opioid use disorder. [PDF]
Roberts E+6 more
europepmc +1 more source
ABSTRACT Introduction Abdominal distension is an objective visible sign of increased abdominal girth. Bloating is a feeling of abdominal fullness and discomfort. Bloating may be associated or not with abdominal distension. Bloating and abdominal distension are among the most commonly reported gastrointestinal symptoms and may be associated with both ...
Chloé Melchior+20 more
wiley +1 more source
Effectiveness of Washington State's hub and spoke model to improve opioid use disorder outcomes. [PDF]
Reif S+7 more
europepmc +1 more source
ABSTRACT Background Remimazolam is a short‐acting benzodiazepine with less cardiorespiratory depression compared with propofol. The Oxygen Reserve Index (ORi) reflects oxygenation status in the mild hyperoxic range and can detect subtle respiratory depression induced by sedatives.
Jee Hoon Kim+9 more
wiley +1 more source
(240) Psychological flexibility and chronic pain characteristics in patients seeking treatment for opioid use disorder [PDF]
Megan E. Curtis+2 more
openalex +1 more source